The agreement terms were not disclosed, but Genstar targets companies with $50 million to $1 billion enterprise values and annual earnings of more than $15 million.
More Articles on Orthopedic Devices:
DePuy Synthes Trauma Launches Radial Head Prosthesis
Zimmer Insider Sells 21k+ Shares
5 New Spine & Orthopedic Device Launches, Releases, Approvals
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
